Elevated serum ferritin level as a predictor of reduced survival in patients with sporadic amyotrophic lateral sclerosis in China: a retrospective study

References

• Oshiro S, Morioka MS, Kikuchi M. Dysregulation of iron metabolism in Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Adv Pharmacol Sci. 2011;2011:378278.
   PubMedGoogle Scholar
• Freinbichler W, Colivicchi MA, Stefanini C, Bianchi L, Ballini C, Misini B. Highly reactive oxygen species: detection, formation, and possible functions. Cell Mol Life Sci. 2011;68:2067–79.
   PubMed Web of Science ®Google Scholar
• Ince PG, Shaw PJ, Candy JM, Mantle D, Tandon L, Ehmann WD, et al. Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci Lett. 1994;182:87–90.
   PubMed Web of Science ®Google Scholar
• Emerit J, Edeas M, Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother. 2004;58:39–46.
   PubMed Web of Science ®Google Scholar
• Yu J, Qi F, Wang N, Gao P, Dai S, Lu Y, et al. Increased iron level in motor cortex of amyotrophic lateral sclerosis patients: an in vivo MR study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:357–61.
   PubMed Web of Science ®Google Scholar
• Jeong SY, Rathore KI, Schulz K, Ponka P, Arosio P, David S. Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci. 2009;29:610–9.
   PubMed Web of Science ®Google Scholar
• Nadjar Y, Gordon P, Corcia P, Bensimon G, Pieroni L, Meininger V, et al. Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis. PLoS One. 2012;7:e45034.
   PubMed Web of Science ®Google Scholar
• Goodall EF, Haque MS, Morrison KE. Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients. J Neurol. 2008;255:1652–6.
   PubMed Web of Science ®Google Scholar
• Veyrat-Durebex C, Corcia P, Mucha A, Benzimra S, Mallet C, Gendrot C, et al. Iron metabolism disturbance in a French cohort of ALS patients. Biomed Res Int. 2014;2014:485723.
   PubMed Web of Science ®Google Scholar
• Mitchell RM, Simmons Z, Beard JL, Stephens HE, Connor JR. Plasma biomarkers associated with ALS and their relationship to iron homeostasis. Muscle Nerve. 2010;42:95–103.
   PubMed Web of Science ®Google Scholar
• Qureshi M, Brown RH, Rogers JT, Cudkowicz ME. Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis. Open Neurol J. 2008;2:51–4.
   PubMedGoogle Scholar
• Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study. Intern Med. 2012;51:1501–8.
   PubMed Web of Science ®Google Scholar
• Su XW, Clardy SL, Stephens HE, Simmons Z, Connor JR. Serum ferritin is elevated in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:102–7.
   PubMed Web of Science ®Google Scholar
• Goodall EF, Greenway MJ, van Marion I, Carroll CB, Hardiman O, Morrison KE. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS. Neurology. 2005;65:934–7.
   PubMed Web of Science ®Google Scholar
• Wang X-S, Lee S, Simmons Z, Boyer P, Scott K, Liu W, et al. Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences. J Neurol Sci. 2004;227:27–33.
   PubMed Web of Science ®Google Scholar
• He X, Lu X, Hu J, Xi J, Zhou D, Shang H, et al. H63D polymorphism in the hemochromatosis gene is associated with sporadic amyotrophic lateral sclerosis in China. Eur J Neurol. 2011;18:359–61.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Gao L, Wang D, Zang D. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Acta Neurol Scand. 2017;136:145–50.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1:293–9.
   PubMed Web of Science ®Google Scholar
• Stefanova N, Bücke P, Duerr S, Wenning GK. Multiple system atrophy: an update. Lancet Neurol. 2009;8:1172–8.
   PubMed Web of Science ®Google Scholar
• Kubota K, Tamura J, Kurabayashi H, Shirakura T, Kobayashi I. Evaluation of increased serum ferritin levels in patients with hyperthyroidism. Clin Investig. 1993;72:26–9.
   PubMedGoogle Scholar
• Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010; 1800:760.
   PubMed Web of Science ®Google Scholar
• Kolodziej MA, Proemmel P, Quint K, Strik HM. Cerebrospinal fluid ferritin-unspecific and unsuitable for disease monitoring. Neurol Neurochir Pol. 2014; 48:116–21.
   PubMed Web of Science ®Google Scholar
• Sato Y, Honda Y, Asoh T, Oizumi K, Ohshima Y, Honda E. Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis. J Neurooncol. 1998;40:47–50.
   PubMed Web of Science ®Google Scholar
• Tortelli R, Copetti M, Panza F, Cortese R, Capozzo R, D’Errico E, et al. Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2016;87:678–9.
   PubMed Web of Science ®Google Scholar
• Strong M, Rosenfeld J. Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:136–43.
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Cheung YK. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;67:1314–5. author reply 1314–5.
   PubMed Web of Science ®Google Scholar
• Dexter DT, Jenner P, Schapira AH, Marsden CD; The Royal Kings and Queens Parkinson’s Disease Research Group. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol. 1992;32:S94–S100. Suppl:
   PubMed Web of Science ®Google Scholar
• Visanji NP, Collingwood JF, Finnegan ME, Tandon A, House E, Hazrati LN. Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson’s disease and multiple system atrophy. J Parkinsons Dis. 2013; 3:523–37.
   PubMedGoogle Scholar
• Kuiper MA, Mulder C, Kamp GJ, Scheltens P, Wolters EC. Cerebrospinal fluid ferritin levels of patients with Parkinson’s disease, Alzheimer’s disease, and multiple system atrophy. J Neural Transm Gen Sect. 1994;7:109–14.
   Google Scholar